Spot Trading L.L.C - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spot Trading L.L.C ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$13,000
-84.1%
11,150
+1.4%
0.00%
-100.0%
Q3 2015$82,000
-95.6%
11,000
-94.1%
0.00%
-90.9%
Q4 2014$1,845,000
+40.6%
185,020
+39.6%
0.01%
+57.1%
Q3 2014$1,312,000
+180.9%
132,565
+404.0%
0.01%
+133.3%
Q1 2014$467,000
+151.1%
26,300
+157.8%
0.00%
+200.0%
Q4 2013$186,000
-97.9%
10,200
-96.8%
0.00%
-98.1%
Q3 2013$8,657,000323,0600.05%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 778,800$935,0000.18%
Allegis Investment Advisors, LLC 366,190$439,0000.12%
GENERAL AMERICAN INVESTORS CO INC 589,768$708,0000.07%
Acrospire Investment Management LLC 24,881$30,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 114,165$137,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$13,0000.00%
Renaissance Technologies 727,113$873,0000.00%
BALDWIN BROTHERS LLC/MA 1,750$2,0000.00%
VANGUARD GROUP INC 889,850$1,068,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 150$00.00%
View complete list of REPROS THERAPEUTICS INC shareholders